HANBIO THERAPEUTICS
HanBio Therapeutics is a biotechnology company committed to researching and developing next generation transformative medicines.
HANBIO THERAPEUTICS
Industry:
Biotechnology Therapeutics
Address:
Shanghai, Shanghai, China
Country:
China
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40 M USD
Similar Organizations
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Investors List
OrbiMed
OrbiMed investment in Series A - HanBio Therapeutics
Yonghua Capital
Yonghua Capital investment in Series A - HanBio Therapeutics
Elikon Venture
Elikon Venture investment in Series A - HanBio Therapeutics
Hankang Capital
Hankang Capital investment in Series A - HanBio Therapeutics
More informations about "HanBio Therapeutics"
HanBio Therapeutics Company Profile 2024: Valuation, …
HanBio Therapeutics General Information Description. Researcher and provider of novel medicines for serious diseases. The company focuses on researching and developing transformative medicines for serious diseases, including …See details»
HanBio Therapeutics Announces the Completion of a US$40 …
Jan 29, 2022 HanBio Therapeutics is an innovative biotechnology company committed to researching and developing next generation transformative medicines to treat patients with …See details»
HanBio Therapeutics - Company Profile - Tracxn
Dec 5, 2024 HanBio Therapeutics - R&D company focused on manufacturing of drugs for multiple therapeutic areas. Raised a total funding of $40M over 1 round from 3 investors. …See details»
HanBio Therapeutics - Funding, Financials, Valuation & Investors
HanBio Therapeutics is a biotechnology company committed to researching and developing next generation transformative medicines. Search Crunchbase. ... How much funding has this …See details»
HanBio Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for HanBio Therapeutics Inc. of Shanghai, Shanghai. Get the latest business insights from Dun & Bradstreet.See details»
HanBio Therapeutics - Products, Competitors, Financials, …
HanBio Therapeutics is a biotechnology company that researches and develops medicines to treat patients with serious diseases. Use the CB Insights Platform to explore HanBio …See details»
HanBio Therapeutics Announces the Completion of a US$40 …
Jan 29, 2022 HanBio Therapeutics is an innovative biotechnology company committed to researching and developing next generation transformative medicines to treat patients with …See details»
HanBio Therapeutics Announces the Completion of a US$40 …
SHANGHAI, Jan. 29, 2022 /PRNewswire/ -- HanBio Therapeutics ("HanBio"), a biotechnology company committed to researching and developing next generation transformative medicines, …See details»
HanBio Therapeutics - Crunchbase
HanBio Therapeutics is a biotechnology company committed to researching and developing next generation transformative medicines.See details»
HanBio Therapeutics Announces the Completion of a US$40
SHANGHAI, Jan. 29, 2022 /PRNewswire/ -- HanBio Therapeutics ("HanBio"), a biotechnology company committed to researching and developing next generation transformative medicines, …See details»
HanBio Therapeutics - Raised $40M Funding from 3 investors
HanBio Therapeutics has raised a total funding of $40M over 1 round from 3 investors. Investors include Orbimed, Yonghua Capital and 1 other. Their latest funding round was of $40M on Jan …See details»
HanBio Therapeutics Announces the Completion of a US$40
HanBio Therapeutics, a biotechnology company committed to researching and developing next generation transformative medicines, announced that it has completed a US$40 million Series …See details»
Series A - HanBio Therapeutics - 2022-01-28 - Crunchbase
Jan 28, 2022 Organization Name . HanBio Therapeutics . Announced Date Jan 28, 2022; Closed On Date Jan 28, 2022; Funding Type Series A; Funding Stage Early Stage Venture; …See details»
HanBio Therapeutics Announces the Completion of a US$40 …
SHANGHAI, Jan. 28, 2022 /PRNewswire/ -- HanBio Therapeutics ("HanBio"), a biotechnology company committed to researching and developing next generation transformative medicines, …See details»
HanBio Therapeutics Stock Price, Funding, Valuation, Revenue ...
See HanBio Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on HanBio Therapeutics's post-money valuation and revenue. HanBio …See details»
HanBio Raises $40 Million for BiSpecific Antibody Portfolio
Shanghai 's HanBio Therapeutics raised $40 million in a Series A financing to advance its innovative biologic products. HanBio is an early R&D company that was incubated by …See details»
HanBio Therapeutics - Updates, News, Events, Signals & Triggers
Edit Recent News & Activity Section. Funding Round • Jan 28, 2022. HanBio Therapeutics raised $40,000,000 / Series A from Elikon Venture raised $40,000,000 / Series A from Elikon VentureSee details»
HanBio Therapeutics Announces the Completion of a US$40 …
SHANGHAI, Jan. 29, 2022 /PRNewswire/ — HanBio Therapeutics (“HanBio”), a biotechnology company committed to researching and developing next generation transformative medicines, …See details»
HanBio Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. HanBio Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Edit Patents and Trademarks by IPqwery …See details»